PubRank

Steven J Chmura

Author PubWeight™ 34.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007 2.44
2 Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005 1.85
3 Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2011 1.70
4 An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res 2008 1.68
5 Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007 1.62
6 Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2004 1.52
7 MicroRNA expression characterizes oligometastasis(es). PLoS One 2011 1.45
8 Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 2011 1.42
9 Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005 1.38
10 A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 2009 1.16
11 Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One 2012 1.11
12 Predictors of competing mortality in early breast cancer. Cancer 2010 1.08
13 Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients. Int J Radiat Oncol Biol Phys 2011 1.03
14 A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Biol 2010 1.03
15 An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol 2014 1.02
16 Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. Am J Clin Oncol 2017 0.97
17 Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer 2008 0.96
18 Radiation oncology fourth-year medical student clerkships: a targeted needs assessment. Int J Radiat Oncol Biol Phys 2012 0.93
19 Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003 0.92
20 Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol 2012 0.91
21 AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol 2010 0.90
22 Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Cancer 2005 0.88
23 Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series. Am J Clin Oncol 2014 0.85
24 Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol 2006 0.81
25 Characterization of a novel phantom for three-dimensional in vitro cell experiments. Phys Med Biol 2009 0.81
26 The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. Radiat Oncol 2012 0.81
27 Rationally simplified bistramide analog reversibly targets actin polymerization and inhibits cancer progression in vitro and in vivo. J Am Chem Soc 2010 0.79
28 A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys 2012 0.79
29 Treatment of brain metastases. Oncology 2014 0.78
30 Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era. Cancer Med 2015 0.77
31 Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys 2010 0.77
32 Enhancing radiotherapy with genetically engineered viruses. J Clin Oncol 2007 0.76
33 Effect of RTOG breast/chest wall guidelines on dose-volume histogram parameters. J Appl Clin Med Phys 2014 0.75
34 Is postmastectomy radiotherapy useful in elderly women with high-risk breast cancer? Nat Clin Pract Oncol 2006 0.75
35 Evolving use of radiotherapy and radiosurgery in the treatment of pituitary adenomas. Expert Rev Anticancer Ther 2006 0.75
36 Optimization of the temporal pattern of radiation: an IMRT based study. Int J Radiat Oncol Biol Phys 2006 0.75
37 Validation of temporal optimization effects for a single fraction of radiation in vitro. Int J Radiat Oncol Biol Phys 2009 0.75